212 related articles for article (PubMed ID: 15293271)
1. Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro.
Kraus J; Ling AK; Hamm S; Voigt K; Oschmann P; Engelhardt B
Ann Neurol; 2004 Aug; 56(2):192-205. PubMed ID: 15293271
[TBL] [Abstract][Full Text] [Related]
2. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
[TBL] [Abstract][Full Text] [Related]
3. Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study.
Santaguida S; Janigro D; Hossain M; Oby E; Rapp E; Cucullo L
Brain Res; 2006 Sep; 1109(1):1-13. PubMed ID: 16857178
[TBL] [Abstract][Full Text] [Related]
4. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability.
Stamatovic SM; Shakui P; Keep RF; Moore BB; Kunkel SL; Van Rooijen N; Andjelkovic AV
J Cereb Blood Flow Metab; 2005 May; 25(5):593-606. PubMed ID: 15689955
[TBL] [Abstract][Full Text] [Related]
5. Influence of basolateral condition on the regulation of brain microvascular endothelial tight junction properties and barrier function.
Colgan OC; Collins NT; Ferguson G; Murphy RP; Birney YA; Cahill PA; Cummins PM
Brain Res; 2008 Feb; 1193():84-92. PubMed ID: 18177846
[TBL] [Abstract][Full Text] [Related]
6. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
[TBL] [Abstract][Full Text] [Related]
7. Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro.
Kraus J; Voigt K; Schuller AM; Scholz M; Kim KS; Schilling M; Schäbitz WR; Oschmann P; Engelhardt B
Mult Scler; 2008 Jul; 14(6):843-52. PubMed ID: 18505778
[TBL] [Abstract][Full Text] [Related]
8. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
9. Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness.
Cohen-Kashi Malina K; Cooper I; Teichberg VI
Brain Res; 2009 Aug; 1284():12-21. PubMed ID: 19501061
[TBL] [Abstract][Full Text] [Related]
10. Effects of pericytes and various cytokines on integrity of endothelial monolayer originated from blood-nerve barrier: an in vitro study.
Iwasaki T; Kanda T; Mizusawa H
J Med Dent Sci; 1999 Mar; 46(1):31-40. PubMed ID: 12160211
[TBL] [Abstract][Full Text] [Related]
11. Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.
Lu W; Tan YZ; Jiang XG
Yao Xue Xue Bao; 2006 Apr; 41(4):296-304. PubMed ID: 16856472
[TBL] [Abstract][Full Text] [Related]
12. Fluvastatin stabilizes the blood-brain barrier in vitro by nitric oxide-dependent dephosphorylation of myosin light chains.
Kuhlmann CR; Lessmann V; Luhmann HJ
Neuropharmacology; 2006 Sep; 51(4):907-13. PubMed ID: 16872642
[TBL] [Abstract][Full Text] [Related]
13. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells.
Zhu H; Wang Z; Xing Y; Gao Y; Ma T; Lou L; Lou J; Gao Y; Wang S; Wang Y
J Ethnopharmacol; 2012 Jun; 141(2):714-20. PubMed ID: 21920425
[TBL] [Abstract][Full Text] [Related]
14. Specific AHNAK expression in brain endothelial cells with barrier properties.
Gentil BJ; Benaud C; Delphin C; Remy C; Berezowski V; Cecchelli R; Feraud O; Vittet D; Baudier J
J Cell Physiol; 2005 May; 203(2):362-71. PubMed ID: 15493012
[TBL] [Abstract][Full Text] [Related]
15. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
Silwedel C; Förster C
J Neuroimmunol; 2006 Oct; 179(1-2):37-45. PubMed ID: 16884785
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
[TBL] [Abstract][Full Text] [Related]
17. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier.
Lee SW; Kim WJ; Choi YK; Song HS; Son MJ; Gelman IH; Kim YJ; Kim KW
Nat Med; 2003 Jul; 9(7):900-6. PubMed ID: 12808449
[TBL] [Abstract][Full Text] [Related]
18. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
Lu W; Tan YZ; Hu KL; Jiang XG
Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
[TBL] [Abstract][Full Text] [Related]
19. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.
Biernacki K; Antel JP; Blain M; Narayanan S; Arnold DL; Prat A
Arch Neurol; 2005 Apr; 62(4):563-8. PubMed ID: 15824253
[TBL] [Abstract][Full Text] [Related]
20. Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells.
Ohtsuki S; Sato S; Yamaguchi H; Kamoi M; Asashima T; Terasaki T
J Cell Physiol; 2007 Jan; 210(1):81-6. PubMed ID: 16998798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]